Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Multicenter study to optimize methylphenidate therapy in children with ADHD
2005-003387-28Phase 4Terminated
- Sponsor
- Medice
- Start
- Jan 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, single-arm trial of methylphenidate in attention deficit hyperactivity disorder (ADHD) and hyperkinetic disorder, sponsored by Medice. Primary endpoints: Primary response endpoint and Optimal individualized therapy identification. Started Jan 2006; status: terminated.
02
Drugs
methylphenidate
03
Conditions
attention deficit hyperactivity disorder (ADHD)hyperkinetic disorder
Beyond the preview
Go deeper on 2005-003387-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-003387-28.